Perspective: Nonreproductive Sites of Action of Reproductive Hormones
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Estrogens and androgens, the female and male sex hormones responsible for gender dimorphism and reproduction, play also a very important role in tissues and organs that are not directly involved in procreation. In fact, withdrawal of the effects of estrogens at menopause from nonreproductive tissues like the skeleton, the cardiovascular system, and the brain, is a major risk factor for the development of osteoporosis, coronary artery disease, stroke, and perhaps neurodegenerative diseases like Alzheimers. On the other hand, continuous exposure of reproductive tissues to estrogen during the postreproductive part of life, is a risk factor for the development of breast, ovarian, and uterine cancer. During the last decade, there have been significant advances in our understanding of the mechanism of action of sex steroids on the skeleton, the cardiovascular system, and the central nervous system. The purpose of this perspective is to provide a brief outline of these advances with an emphasis on the emergence of several thematic similarities in the action of sex steroids on nonreproductive tissues. For more thorough discussion of this topic, the reader is referred to recent review articles (1–5). Estrogens and androgens influence the development of the skeleton and the linear growth of bones during puberty. In addition, they maintain homeostasis of the adult skeleton during its continuous regeneration by the process of bone remodeling. Linear skeletal growth is governed by the chondrocytes of the growth plate. Maintenance of adult bone mass is controlled by the basic multicellular units—temporary anatomic structures comprising osteoclasts in the front and osteoblasts in the rear. Bone remodeling consists of focal cycles of resorption followed by formation. The rate of remodeling or turnover depends on the number of cycles, but the effects on bone mass depend on the focal balance within each cycle. Estrogens and androgens decrease the number of remodeling cycles by attenuating the birth rate of osteoclasts and osteoblasts, in part by regulating the production of cytokines (6–8). The focal balance between resorption and formation depends on the lifespan of osteoclasts and osteoblasts, reflecting the timing of apoptosis. Apoptosis of osteoclasts and osteoblasts is modulated by sex steroids in opposite directions. Specifically, sex steroids promote osteoclast apoptosis but prevent the apoptosis of osteoblasts and osteocytes (9, 10). Consequently, loss of estrogens in females or androgens in males after maturity leads to an increased rate of bone remodeling and tilts the balance of resorption and formation in favor of the former; thus, loss of bone mass, deeper than normal osteoclast erosion cavities (leading to the removal of some cancellous elements entirely, with the remainder being more widely separated and less well connected), and increased propensity to fractures. Although two recent clinical trials have failed to show a protective effect of HRT in postmenopausal women with preexisting coronary heart disease (11, 12), an extensive body of evidence indicates that estrogens do have atheroprotective properties that result from a variety of actions. Such actions include favorable changes in lipoprotein metabolism and oxidation, modulation of endothelial permeability to low density lipoprotein, as well as regulation of the expression of cytokines and cell adhesion molecules, vascular smooth muscle cell and neointimal proliferation and migration, calcification and platelet adhesion, and aggregation. Evidence from animal and human studies has strongly suggested that estrogens, at physiological levels, also cause vasodilatation (3). This effect is shared by androgens. This finding is consistent with reports that normotensive men have higher plasma testosterone than hypertensive and that angina pectoris can be successfully treated with acute injections of testosterone (13, 14). In the case of either class of sex steroids, the effect on vasodilatation is mediated by activation of endothelial nitric oxide synthase (eNOS), as well as through increased expression of the eNOS and prostacyclin synthase genes, which regulate vascular tone (15, 16). Dihydrotestosterone, on the other hand, has been shown to increase human monocyte adhesion to endothelial cells, a proatherogenic effect that is mediated at least in part by increased endothelial cell-surface expression of vascular cell adhesion molecule 1 (17); this is perhaps one of several reasons for the higher incidence of coronary artery disease in men compared with premenopausal women. In the CNS, besides regulating gonadotropin and PRL secretion and sexual behavior, estrogens influence verbal fluency and memory, fine motor skills, coordination of movement as well as mood (4, 5, 18). In addition, they seem to decrease the risk of neurodegenerative diseases and attenuate injury by suppressing the effects of neurotoxic or ischemic stimuli or increasing the resilience of the br
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045 · cited 1×
“We also speculate that our findings may account for the weak and puzzling skeletal phenotype of the deletion of the ERa or ERb genes in mice (40).”
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964 · cited 1×
“Interestingly, expression of constitutively active Src or stimulation of the endogenous Src/ JNK pathway enhances transcriptional activation of the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER, through a Raf/MEK/ ERK and a MEKK/JNKK/JNK signaling cascades (51, 52).”
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151 · cited 1×
“Nonetheless, from the case of a man with estrogen resistance due to a mutation of the ERa gene (27) and two men with aromatase deficiency (28, 29), it has become clear”
Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Estrogen Actions in the Central Nervous System
McEwen, B. S. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.279 · Cited by 640
Testosterone Relaxes Rabbit Coronary Arteries and Aorta
Yue, P., Chatterjee, K., Beale, C., Poole-Wilson, P. A., & Collins, P. (1995) · Circulation · doi:10.1161/01.cir.91.4.1154 · Cited by 414
Cited by
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Self-citationThe role of estrogen and androgen receptors in bone health and disease
Manolagas, S. C., O'Brien, C. A., & Almeida, M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.179 · Cited by 574
Self-citationManolagas, S. C. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.385 · Cited by 517
Self-citationMäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids
Kousteni, S., Chen, J.-R., Bellido, T., Han, L., Ali, A. A., O'Brien, C. A., Plotkin, L., Fu, Q., Mancino, A. T., Wen, Y., et al. (2002) · Science · doi:10.1126/science.1074935 · Cited by 420
Self-citation
Metadata
- Authors
- Manolagas, S. C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2001-06-01
- Volume
- 142
- Issue
- 6
- Pages
- 2200-2204
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2066245150
- Cited by
- 100
- References
- 11
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perspective: Nonreproductive Sites of Action of Reproductive Hormones. https://app.cochat.ai/papers/10.1210/en.142.6.2200
- The paper
- Manolagas, S. C. (2001). Perspective: Nonreproductive Sites of Action of Reproductive Hormones. Endocrinology. https://doi.org/10.1210/en.142.6.2200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.